Cytochrome P450-null mice

被引：29

作者：

Buters, JTM ^{[1
]}

Doehmer, J

Gonzalez, FJ

机构：

[1] Tech Univ Munich, Inst Toxicol & Environm Hlth, D-80636 Munich, Germany

[2] NCI, Metab Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA

来源：

DRUG METABOLISM REVIEWS | 1999年 / 31卷 / 02期

关键词：

null mice; cytochrome P450; CYP1A1; CYP1A2; CYP1B1; CYP2E1; caffeine; acetaminophen; dimethylbenzo[a]anthracene;

D O I：

10.1081/DMR-100101929

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：437 / 447

页数：11

共 32 条

[1] HUMAN CDNA-EXPRESSED CYTOCHROME-P450 IA2 - MUTAGEN ACTIVATION AND SUBSTRATE-SPECIFICITY [J].

AOYAMA, T ;

GONZALEZ, FJ ;

GELBOIN, HV .

MOLECULAR CARCINOGENESIS, 1989, 2 (04) :192-198

[2] Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2 [J].

Buters, JTM ;

Tang, BK ;

Pineau, T ;

Gelboin, HV ;

Kimura, S ;

Gonzalez, FJ .

PHARMACOGENETICS, 1996, 6 (04) :291-296

[3]

CASAZZA JP, 1984, J BIOL CHEM, V259, P231

[4] ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY [J].

EATON, DL ;

GALLAGHER, EP ;

BAMMLER, TK ;

KUNZE, KL .

PHARMACOGENETICS, 1995, 5 (05) :259-274

[5] CONTRIBUTION OF CYP1A1, AND CYP1A2 TO THE ACTIVATION OF HETEROCYCLIC AMINES IN MONKEYS AND HUMAN [J].

EDWARDS, RJ ;

MURRAY, BP ;

MURRAY, S ;

SCHULZ, T ;

NEUBERT, D ;

GANT, TW ;

THORGEIRSSON, SS ;

BOOBIS, AR ;

DAVIES, DS .

CARCINOGENESIS, 1994, 15 (05) :829-836

[6] IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR [J].

FERNANDEZSALGUERO, P ;

PINEAU, T ;

HILBERT, DM ;

MCPHAIL, T ;

LEE, SST ;

KIMURA, S ;

NEBERT, DW ;

RUDIKOFF, S ;

WARD, JM ;

GONZALEZ, FJ .

SCIENCE, 1995, 268 (5211) :722-726

[7] Lesions of aryl-hydrocarbon receptor-deficient mice [J].

FernandezSalguero, PM ;

Ward, JM ;

Sundberg, JP ;

Gonzalez, FJ .

VETERINARY PATHOLOGY, 1997, 34 (06) :605-614

[8] EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].

GONZALEZ, FJ ;

NEBERT, DW .

TRENDS IN GENETICS, 1990, 6 (06) :182-186

[9]

GONZALEZ FJ, 1996, CYTOCHROMES P450 MET, P183

[10] ROLE OF HUMAN CYTOCHROME-P-450-IIE1 IN THE OXIDATION OF MANY LOW-MOLECULAR-WEIGHT CANCER SUSPECTS [J].

GUENGERICH, FP ;

KIM, DH ;

IWASAKI, M .

CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (02) :168-179

← 1 2 3 4 →